Scalable human ES culture for therapeutic use: propagation, differentiation, genetic modification and regulatory issues
Author:
- 15 November 2007
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 15 (2) , 82-88
Abstract
Embryonic stem cells unlike most adult stem cell populations can replicate indefinitely while preserving genetic, epigenetic, mitochondrial and functional profiles. ESCs are therefore an excellent candidate cell type for providing a bank of cells for allogenic therapy and for introducing targeted genetic modifications for therapeutic intervention. This ability of prolonged self-renewal of stem cells and the unique advantages that this offers for gene therapy, discovery efforts, cell replacement, personalized medicine and other more direct applications requires the resolution of several important manufacturing, gene targeting and regulatory issues. In this review, we assess some of the advance made in developing scalable culture systems, improvement in vector design and gene insertion technology and the changing regulatory landscape.Keywords
This publication has 44 references indexed in Scilit:
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Human Embryonic Stem Cells and Gene TherapyMolecular Therapy, 2007
- Human embryonic stem cells: Long term stability, absence of senescence and a potential cell source for neural replacementNeuroscience, 2007
- Targeted gene addition into a specified location in the human genome using designed zinc finger nucleasesProceedings of the National Academy of Sciences, 2007
- Cardiovascular development: towards biomedical applicabilityCellular and Molecular Life Sciences, 2007
- PiggyBac Transposon-mediated Gene Transfer in Human CellsMolecular Therapy, 2007
- Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditionsProceedings of the National Academy of Sciences, 2006
- Defined culture conditions of human embryonic stem cellsProceedings of the National Academy of Sciences, 2006
- Neurotrophins mediate human embryonic stem cell survivalNature Biotechnology, 2006
- Obtaining an accepted Investigational New Drug application to operate an umbilical cord blood bankTransfusion, 1999